Home › Targets › TR-Beta

TR-Beta (1 companies · 2 programs)

Companies with an active program directed at TR-Beta.

Viking Therapeutics, Inc. VKTX

VK0214 — X-Linked Adrenoleukodystrophy Phase 1
VK2809 — Non-Alcoholic Steatohepatitis Phase 2